marijuana debate because quite frankly I'm a fan of both parties. I also have a lot of ties to Lilly, so I've kind of immersed myself in the medical world and its workings and I get a bit passionate about the whole Lilly vs. Those are the real moneymakers.Īnytime! This ended up being more wholesome than I'm used to when this sort of discussion pops up, so thank you for that 😊 I work in pharmacy, so I'm pretty well versed in Lilly's products and the industry as a whole (or at least moreso than the average person). A vial of synthetic insulin will run about $700/vial. Hell, a single month's supply of Humira is nearly $10,000 at retail price. Biologics are where the money really is today and that's not something that marijuana makes a difference in. So although Lilly has been a producer of SSRIs for a long time (think Prozac), it's no longer something they rely on or really care about in terms of their bottom line. Once a drug goes generic, the original manufacturer loses an enormous amount of money on it and it's no longer the cash cow it once was. Lilly's current top products ranked by revenue The only antidepressant that they have that is profitable is Cymbalta and it's at the bottom of the list. Do you know what Lilly's current most profitable drugs are? Synthetic insulin (4 different variations), biologics for psoriatic and rheumatoid arthritis, an antidiabetic drug for lowering blood sugar, cancer chemotherapy, and an osteoporosis drug in that order.

Is online gambling legal in indiana